Three million people worldwide are taking the new, heavily advertised anti-cholesterol drugs Zetia and Vytorin, despite a lack of clinical evidence that they reduce cardiovascular disease or heart attacks, or help patients live longer. Vytorin and Zetia brought in $5.2 billion last year for Merck and Schering-Plough, placing them among the best-selling drugs in the world. The Food and Drug Administration approves many drugs based on whether they perform a specific action, like lowering cholesterol, without requiring long-term trials on whether they extend life or lower disease risks. Other FDA-approved drugs have been found to be ineffective or even dangerous.
TV News LIES
Establishment News Media...
There is blood on your hands!
1/2 the Story = 1 Complete Lie.
Learn How the Broadcast News
Media Deceive You!
Click Here!
Read The News That "They"
Don't Want You to Notice!
Click Here!
Explore Our Special Coverage
of the Events of 9/11/2001
Click Here!
Sunday, Sep 01st
Last update06:50:01 AM GMT
Headlines